As of 4:00pm ET
| +0.09 / +0.69%|
The 7 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 15.00, with a high estimate of 25.00 and a low estimate of 12.00. The median estimate represents a +13.98% increase from the last price of 13.16.
The current consensus among 8 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.